Your browser doesn't support javascript.
loading
Evaluation of the Clinical and Economic Burden of Poor Glycemic Control Associated with Therapeutic Inertia in Patients with Type 2 Diabetes in the United States.
Ali, Sarah Naz; Dang-Tan, Tam; Valentine, William J; Hansen, Brian Bekker.
Affiliation
  • Ali SN; Novo Nordisk Inc, Plainsboro, NJ, USA. wsna@novonordisk.com.
  • Dang-Tan T; Novo Nordisk Inc, Plainsboro, NJ, USA.
  • Valentine WJ; Ossian Health Economics and Communications, Basel, Switzerland.
  • Hansen BB; Novo Nordisk A/S, Søborg, Denmark.
Adv Ther ; 37(2): 869-882, 2020 02.
Article in En | MEDLINE | ID: mdl-31925649
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Patients / Cost of Illness / Diabetes Mellitus, Type 2 / Medication Adherence / Hypoglycemic Agents / Motivation Type of study: Health_economic_evaluation / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Adv Ther Journal subject: TERAPEUTICA Year: 2020 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Patients / Cost of Illness / Diabetes Mellitus, Type 2 / Medication Adherence / Hypoglycemic Agents / Motivation Type of study: Health_economic_evaluation / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Adv Ther Journal subject: TERAPEUTICA Year: 2020 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos